Tag - tumor

Developments

Soricimed, Image Analysis Group to validate SOR-C13 imaging markers

Soricimed Biopharma entered into a strategic alliance with Image Analysis Group for the development of Soricimed’s lead anti-cancer drug candidate, SOR-C13, a first-in-class inhibitor of the TRPV6 calcium channel. Image...

September 6, 2019

Developments

DelMar Pharma enrolls first patient in adjuvant arm of Phase 2 glioblastoma trial

DelMar Pharmaceuticals (NASDAQ:DMPI) treated the first MGMT-unmethylated glioblastoma multiforme (GBM) patient in the adjuvant trial arm of its Phase 2 study of VAL-083. This study arm will enroll up to 24 newly...

July 24, 2019

Tag - tumor

Soricimed, Image Analysis Group to validate SOR-C13 imaging markers

DelMar Pharma enrolls first patient in adjuvant arm of Phase 2 glioblastoma trial

General

More